Atul Auto | 12.8% |
Sasken | 9.0% |
Alembic | 7.9% |
Swaraj | 7.4% |
NESCO | 7.2% |
MPS | 6.4% |
Gruh | 5.4% |
Accelya Kale | 5.4% |
Poly Medicure | 5.4% |
Natco | 5.2% |
Can Fin | 4.7% |
Torrent | 4.9% |
Eicher | 4.4% |
Ratnamani | 4.3% |
Ajanta Pharma | 3.4% |
Talwalkar | 3.2% |
ENIL | 3.0% |
I own 17 currently. 2 higher than my comfort zone. Can't get around to sell any though. WOULD BE GRATEFUL FOR VIEWS FROM FELLOW VALUE PICKERS
Thoughts on the same
Atul Auto: Started buying at Rs81 levels (split adjusted). Bought more at Rs140 and Rs329. At 81 I think it was a 6-7 PE stock with zero debt, high RoE and RoCE. Now it is expensive. Not got around to selling it. Ramdeo Agarwal (Motilal Oswal) bought at Rs125, Birla MF at Rs150 and HDFC MF at Rs307. Has got coverage in Forbes in Sep14 also.
Sasken: Bought at Rs110 level in May 2012 and have added more at Rs310 levels recently. When I bought it initially it had 40% of market cap in cash. Clean promoters who pay dividends and do buyback. They once again have lot of cash after recent settlement which made me add more.
Alembic Pharma: Bought in May2013. Stock was at 13-14x P/E. Zero debt. High RoE and RoCE. So bought it
Swaraj Engines: Bought at Rs400, Rs641, Rs715 and Rs890. Low P/E. High RoE and RoCe. Supplying engines to the market leader M&M. given Kirloskar is also a large shareholder M&M is being forced to give very healthy dividends which keeps RoE high and shareholder happy.
NESCO: Inspired by Sanjay Bakshi's note and bought at Rs600 levels. Have added more recently at Rs1266 levels. Had also bought Piramal Healthcare inspired him but thankfully better sense prevailed and I sold out.
MPS: Bought at Rs335 levels inspired by Ajay Relan's comments and research done by esteemed value pickers
Gruh Finance: When I invest I need to see a cash flow statement. That is why I find it hard to buy financial companies. Gruh business model appealed to me. I felt it could grow 20-30% for the next 10 years and off course the HDFC pedigree. Bought a crazy valuations of 6-7x P/BV at Rs112. Has perhaps gone at 10x P/BV. Quite crazy dont you think
Accelya Kale: High RoE and RoCE. Clean promoters and high dividends. Niche business. But can it grow? When will investors wake up to the value in this stock?
Poly Medicure: Saw this 1.5 year back. Did not buy as market cap was small and valuations high. Stock doubled and I was kicking myself. Bought it at Rs475 levels sometime back.
Natco Pharma: Bought at Rs636 for copaxone. Then thought if they can make copaxone they can make more block buster drugs in the future. Decided to hold long term
Can Fin: Wanted to buy one more finance stock after Gruh. Looked at Bajaj Finserv, J&K Bank, Federal Bank. Then saw REPCO, Can Fin and Dewan. Like Can Fin and bought it.
Torrent Pharma: Had collapsed to Rs470 levels after Elder Pharma acquisition. Thought it was very cheap. Bought it as I have a good view about promoters
Eicher Motors: Missed the massive rally. Read about it in VP. Liked the 6 month waiting period on Enfield bikes. Felt bikes can grow 40-50% for next 3 years and off course if Volvo JV turns around could get interesting given where Ashok Leyland is trading. Bought at Rs10050.
Ratnamani metals and tubes: Only zero debt pipes company with high RoE and RoCE. Nalanda Capital presence was another positive. Bought at Rs376.
Ajanta Pharma: Missed buying in May 2013. Bought it today as it is cheaper than Alembic and I continue to own Alembic
Talwalkar: I think this is a unique play. Can grow 15-20% for the next 10 years. Only way to play gyms in India. So bought at Rs140
ENIL: Radio Mirchi waiting for Phase III auctions with lots of cash on books.